To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MS4A6ATABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
391 supporting clones for gene MS4A6A back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CR606472 Placenta Cot 25-normalized .a 1 to 1160 1 to 1160 exact tiling clone,   1160/1160
(100 %)
0 diff
(100 %id)
BX377033 Placenta Cot 25-normalized .a 1 to 480 1 to 484   fully sequenced,   484/484
(100 %)
1 diff
(99.8 %id)
DC340281 thalamus .a 193 to 825 1 to 634       634/634
(100 %)
4 diff
(99.4 %id)
DC385927 skeletal muscle .a 201 to 756 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
BX377032 Placenta Cot 25-normalized .a 419 to 1139 742 to 21   fully sequenced,   722/742
(97 %)
9 diff
(98.8 %id)
TI_57234474   .b 1 to 873 37 to 914   tiling clone,   878/925
(94 %)
26 diff
(97.2 %id)
BI908327 leukocyte .b 4 to 873 1 to 875   tiling clone,   875/886
(98 %)
20 diff
(97.8 %id)
BQ109485 leukocyte .b 4 to 670 1 to 666   tiling clone,   666/689
(96 %)
8 diff
(98.9 %id)
DC388745 small intestine .b 23 to 589 1 to 568       568/568
(100 %)
2 diff
(99.7 %id)
AK300725 skeletal muscle .b 219 to 1437 1 to 1219 T213S tiling clone,   1219/1219
(100 %)
7 diff
(99.5 %id)
AK291870 skeletal muscle .c 1 to 1382 2 to 1383 exact tiling clone,   1383/1383
(100 %)
0 diff
(100 %id)
DA894154 skeletal muscle .c 1 to 569 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
AF212240 pheochromocytoma .c 255 to 1383 1 to 1128 exact     1128/1131
(99 %)
6 diff
(99.5 %id)
AF237908 liver; spleen .c 255 to 1382 1 to 1128 exact AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1128/1128
(100 %)
5 diff
(99.6 %id)
AF253977   .c 255 to 1382 1 to 1131 S116K S117Q L118A V119W G120L ... AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1131/1131
(100 %)
8 diff
(99.3 %id)
AF261136 dentritic cell .c 255 to 1382 1 to 1128 S68F A69C S70F F71L S72L ... AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1128/1128
(100 %)
11 diff
(99.1 %id)
H95741 liver and spleen .c 255 to 609 1 to 358       358/358
(100 %)
13 diff
(96.4 %id)
NM_152852.1   .c 255 to 1789 1 to 1535 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1535/1535
(100 %)
1 diff
(100.0 %id)
T70436 liver and spleen .c 285 to 645 1 to 371       371/443
(83 %)
16 diff
(96.4 %id)
CB955705 Pooled-Glandular .c 296 to 1006 1 to 723       723/725
(99 %)
29 diff
(96.0 %id)
BG622477 placenta .c 297 to 958 1 to 663       663/663
(100 %)
13 diff
(98.1 %id)
BX483589   .c 299 to 951 1 to 655       653/657
(99 %)
4 diff
(99.4 %id)
DA583879 lung .c 299 to 880 2 to 584   capped   583/583
(100 %)
3 diff
(99.5 %id)
DA917243 small intestine .c 302 to 873 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
BG434194 placenta .c 313 to 961 1 to 647       649/648
(100 %)
6 diff
(99.1 %id)
DA168341 amygdala .c 315 to 871 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
FN137875 breast carcinoma .c 319 to 418 101 to 1     Submitted on the opposite strand 101/101
(100 %)
1 diff
(99.1 %id)
FN081274 breast carcinoma .c 320 to 371 1 to 52       52/53
(98 %)
2 diff
(96.3 %id)
CB157025 Liver .c 327 to 873 1 to 547       547/547
(100 %)
0 diff
(100 %id)
FN175159 breast carcinoma .c 328 to 408 1 to 81       81/81
(100 %)
4 diff
(95.1 %id)
FN094143 breast carcinoma .c 331 to 412 1 to 82       82/82
(100 %)
4 diff
(95.2 %id)
DA595451 lung .c 331 to 899 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA939833 Spleen .c 331 to 925 2 to 596   capped   595/595
(100 %)
2 diff
(99.7 %id)
CD697064 normal nasopharynx .c 334 to 721 1 to 393       393/393
(100 %)
7 diff
(98.3 %id)
DA594886 lung .c 340 to 911 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA591789 lung .c 346 to 908 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DB102492 thymus .c 346 to 898 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
BU929268 placenta .c 351 to 967 1 to 618       618/649
(95 %)
8 diff
(98.8 %id)
H13072 placenta .c 352 to 740 1 to 399       399/403
(99 %)
11 diff
(97.3 %id)
BQ716319 sympathetic trunk .c 352 to 732 1 to 383       383/983
(38 %)
6 diff
(99.4 %id)
DN998224 breast cancer, Mammary gland (cancer tissue) .c 354 to 714 9 to 369       361/369
(97 %)
8 diff
(97.9 %id)
DA979138 synovial membrane tissue from rheumatioidarthritis .c 355 to 909 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
CD683816 normal nasopharynx .c 365 to 878 25 to 538       514/538
(95 %)
8 diff
(98.6 %id)
CD687807 normal nasopharynx .c 365 to 755 26 to 416       391/416
(93 %)
7 diff
(98.4 %id)
CD691679 normal nasopharynx .c 365 to 834 25 to 494       470/495
(94 %)
8 diff
(98.4 %id)
CD704850 normal nasopharynx .c 365 to 942 32 to 609       578/609
(94 %)
12 diff
(98.1 %id)
CD706640 normal nasopharynx .c 365 to 927 15 to 578       564/578
(97 %)
9 diff
(98.5 %id)
BI911270 leukocyte .c 366 to 1225 28 to 885       858/885
(96 %)
11 diff
(98.8 %id)
TI_57231847   .c 366 to 1225 28 to 885       858/885
(96 %)
11 diff
(98.8 %id)
DR001532 fetal brain .c 367 to 1064 1 to 694       694/694
(100 %)
10 diff
(98.6 %id)
DA975447 synovial membrane tissue from rheumatioidarthritis .c 368 to 919 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
BG567731 Liver .c 369 to 1194 1 to 828       828/857
(96 %)
20 diff
(97.7 %id)
BX495864 Liver .c 370 to 806 1 to 437       437/437
(100 %)
3 diff
(99.4 %id)
FN155594 breast carcinoma .c 370 to 448 1 to 78       78/78
(100 %)
4 diff
(94.9 %id)
CB958215 Pooled-Glandular .c 370 to 1039 1 to 680       680/873
(77 %)
16 diff
(98.2 %id)
CB957281 Pooled-Glandular .c 370 to 1151 1 to 789       789/793
(99 %)
16 diff
(98.0 %id)
CD102997 Pooled-Skin .c 370 to 830 1 to 467       467/915
(51 %)
14 diff
(98.5 %id)
CD299666 Pooled-Skin .c 370 to 781 1 to 417       417/811
(51 %)
13 diff
(98.4 %id)
BX496665 Liver .c 371 to 1101 1 to 731       731/731
(100 %)
2 diff
(99.8 %id)
BG546745 lung .c 372 to 1045 1 to 677       677/680
(99 %)
10 diff
(98.6 %id)
FN053647 breast carcinoma .c 373 to 472 100 to 1     Submitted on the opposite strand 100/101
(99 %)
1 diff
(99.1 %id)
CB991700 placenta, pre-eclamptic placenta .c 373 to 1085 21 to 742       722/803
(89 %)
20 diff
(97.6 %id)
FN148980 breast carcinoma .c 375 to 455 1 to 81       81/81
(100 %)
5 diff
(93.9 %id)
CD357353 Blood vessels - aorta, basilar and artery .c 377 to 921 1 to 551       551/797
(69 %)
20 diff
(97.5 %id)
FN098568 breast carcinoma .c 379 to 448 1 to 70       70/71
(98 %)
3 diff
(95.8 %id)
CD241916 Blood vessels - aorta, basilar and artery .c 379 to 1134 1 to 762       762/762
(100 %)
10 diff
(98.7 %id)
CD710071 normal nasopharynx .c 380 to 767 23 to 413       391/413
(94 %)
10 diff
(97.6 %id)
BF574865 muscle (skeletal) .c 381 to 1039 1 to 665       665/853
(77 %)
27 diff
(96.9 %id)
DB200665 trachea .c 381 to 957 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
BX646347   .c 382 to 901 1 to 518       520/518
(100 %)
2 diff
(99.7 %id)
BF106072 lung .c 382 to 1031 1 to 642       642/840
(76 %)
33 diff
(96.1 %id)
AV715678   .c 383 to 1116 1 to 735       735/735
(100 %)
1 diff
(99.9 %id)
DA938165 Spleen .c 383 to 984 2 to 605   capped   604/604
(100 %)
4 diff
(99.4 %id)
DA894277 skeletal muscle .c 384 to 933 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
BC022854 skeletal muscle .c 386 to 1789 1 to 1404 T185S tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1404/1404
(100 %)
6 diff
(99.6 %id)
FN172105 breast carcinoma .c 387 to 472 87 to 1     Submitted on the opposite strand 87/88
(98 %)
1 diff
(98.9 %id)
AV717053   .c 388 to 949 16 to 577       562/577
(97 %)
21 diff
(96.4 %id)
R97144 liver and spleen .c 389 to 774 10 to 403       394/474
(83 %)
18 diff
(96.3 %id)
BG537853 lung .c 389 to 1034 1 to 647       647/1080
(59 %)
13 diff
(98.8 %id)
TI_57180699   .c 390 to 1265 64 to 936 exact     873/936
(93 %)
11 diff
(98.9 %id)
AA421911 ovarian tumor, ovary .c 391 to 834 1 to 444       444/444
(100 %)
2 diff
(99.6 %id)
BF338621 brain, glioblastoma with EGFR amplification .c 392 to 1147 1 to 749       751/904
(83 %)
22 diff
(97.6 %id)
CF596933 ovary .c 392 to 1039 1 to 652       652/947
(68 %)
17 diff
(98.3 %id)
N73170 liver and spleen .c 393 to 732 1 to 340       340/340
(100 %)
5 diff
(98.6 %id)
AA035208 uterus .c 394 to 809 1 to 420       420/420
(100 %)
5 diff
(98.9 %id)
BI766801 pooled lung and spleen .c 394 to 1265 1 to 869 exact     869/869
(100 %)
5 diff
(99.5 %id)
T81549 liver and spleen .c 398 to 741 1 to 356       356/385
(92 %)
15 diff
(96.2 %id)
CB959324 Pooled-Glandular .c 401 to 1013 1 to 624       624/814
(76 %)
36 diff
(95.6 %id)
CD107162 brain, Pituitary .c 402 to 1267 1 to 872 N229K S230F G231W M232H S233V ...     872/877
(99 %)
7 diff
(99.3 %id)
CD683990 normal nasopharynx .c 404 to 841 46 to 483       438/483
(90 %)
6 diff
(98.8 %id)
CD705842 normal nasopharynx .c 404 to 768 43 to 408       366/408
(89 %)
9 diff
(97.8 %id)
BE928787 lung_tumor .c 407 to 529 150 to 25       126/155
(81 %)
1 diff
(99.4 %id)
AF350502   .c 408 to 1382 1 to 975 K107R T110S S225R AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 975/975
(100 %)
6 diff
(99.4 %id)
AA380214 skin .c 415 to 708 1 to 295       295/295
(100 %)
2 diff
(99.4 %id)
H64963 liver and spleen .c 416 to 867 1 to 454       454/455
(99 %)
9 diff
(98.1 %id)
CB164083 Liver .c 416 to 1086 1 to 671       671/671
(100 %)
0 diff
(100 %id)
BX104965 liver and spleen .c 417 to 1095 1 to 678       678/678
(100 %)
1 diff
(99.9 %id)
DA971486 synovial membrane tissue from rheumatioidarthritis .c 418 to 948 2 to 532   capped   531/531
(100 %)
1 diff
(99.9 %id)
DA983620 synovial membrane tissue from rheumatioidarthritis .c 419 to 983 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
AA975342 carcinoid, lung .c 431 to 797 367 to 1       367/367
(100 %)
0 diff
(100 %id)
BE467132 carcinoid, lung .c 431 to 807 377 to 1       377/377
(100 %)
0 diff
(100 %id)
AV661743 corresponding non cancerous liver tissue .c 441 to 950 1 to 510     Submitted on the opposite strand 510/619
(82 %)
3 diff
(99.6 %id)
AI635515 pooled germ cell tumors .c 442 to 877 1 to 436     Submitted on the opposite strand 436/436
(100 %)
1 diff
(99.8 %id)
W03796 liver and spleen .c 447 to 924 1 to 485       485/485
(100 %)
10 diff
(98.0 %id)
TI_57200466   .c 447 to 1371 34 to 951 I227M G228V N229I S230L G231A ...     918/968
(94 %)
34 diff
(96.5 %id)
BI821317 pooled brain, lung, testis .c 448 to 1371 1 to 917 I227M G228V N229I S230L G231A ...     917/934
(98 %)
28 diff
(97.1 %id)
BG434337 placenta .c 471 to 984 1 to 514       514/515
(99 %)
1 diff
(99.9 %id)
BE718457 head_neck .c 472 to 756 311 to 29       283/311
(90 %)
0 diff
(100 %id)
BE831336 marrow .c 472 to 767 1 to 296       296/296
(100 %)
6 diff
(98.0 %id)
TI_149273424   .c 473 to 1382 989 to 85 T2P S3P Q4T P5C V6S ... AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 905/1028
(88 %)
65 diff
(93.7 %id)
BE718394 head_neck .c 474 to 759 296 to 14       283/298
(94 %)
2 diff
(99.4 %id)
BE831335 marrow .c 474 to 758 287 to 1       287/289
(99 %)
12 diff
(95.9 %id)
CR612280 Placenta Cot 25-normalized .c 474 to 1375 1 to 902 exact     902/902
(100 %)
0 diff
(100 %id)
BX358910 Placenta Cot 25-normalized .c 474 to 1370 1 to 896 K209E Q210X L220X I227X N229X ... fully sequenced,   896/896
(100 %)
11 diff
(98.8 %id)
AF286866 liver; spleen .c 477 to 1382 1 to 906 exact AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 906/906
(100 %)
1 diff
(99.9 %id)
H94235 liver and spleen .c 479 to 772 1 to 298       298/298
(100 %)
4 diff
(98.7 %id)
TI_1948216770   .c 492 to 1143 124 to 778       655/1439
(45 %)
27 diff
(98.2 %id)
TI_1948216771   .c 492 to 795 129 to 432       304/330
(92 %)
6 diff
(98.2 %id)
TI_1948217103   .c 492 to 1142 125 to 778       654/1388
(47 %)
23 diff
(98.4 %id)
TI_1948217104   .c 492 to 774 128 to 410       283/309
(91 %)
7 diff
(97.8 %id)
TI_1948217105   .c 492 to 1243 873 to 123 T2Q T185S E244N L245Y L246*     751/1201
(62 %)
7 diff
(99.5 %id)
TI_1948217435   .c 492 to 773 128 to 409       282/309
(91 %)
6 diff
(98.1 %id)
TI_1948217436   .c 492 to 1243 872 to 122 F21S S22P Q23K A24Q E25R ...     751/1221
(61 %)
4 diff
(99.7 %id)
TI_1948217744   .c 492 to 1234 126 to 874       747/1447
(51 %)
43 diff
(97.1 %id)
TI_1948217745   .c 492 to 1243 129 to 881 T185S L245P L246I T247D S248F     753/1388
(54 %)
14 diff
(99.0 %id)
EL735363 mixed .c 493 to 1108 1 to 615       615/615
(100 %)
4 diff
(99.4 %id)
TI_154119406   .c 502 to 1382 945 to 78   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 868/978
(88 %)
21 diff
(97.9 %id)
FN107439 breast carcinoma .c 584 to 675 94 to 1     Submitted on the opposite strand 94/95
(98 %)
1 diff
(99.0 %id)
AI263085 Kidney .c 613 to 1383 773 to 4       770/773
(99 %)
4 diff
(99.5 %id)
AA160278   .c 632 to 1072 1 to 442   fully sequenced,   442/442
(100 %)
1 diff
(99.8 %id)
FN092793 breast carcinoma .c 639 to 734 92 to 1     Submitted on the opposite strand 92/96
(95 %)
3 diff
(96.9 %id)
CB045884 2 pooled tumors (clear cell type), Kidney .c 647 to 1080 7 to 440     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 434/440
(98 %)
17 diff
(96.2 %id)
FN138431 breast carcinoma .c 651 to 746 1 to 96       96/96
(100 %)
3 diff
(96.9 %id)
BQ003409 Chondrosarcoma, Left Pelvis .c 654 to 1378 743 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 726/726
(100 %)
4 diff
(99.5 %id)
TI_1948217437   .c 661 to 1243 721 to 124       598/1416
(42 %)
27 diff
(98.1 %id)
TI_1948216773   .c 668 to 1243 713 to 132       580/1409
(41 %)
14 diff
(99.1 %id)
FN094542 breast carcinoma .c 670 to 774 1 to 104       104/108
(96 %)
2 diff
(98.2 %id)
FN153139 breast carcinoma .c 675 to 755 1 to 80       80/80
(100 %)
4 diff
(95.0 %id)
FN117874 breast carcinoma .c 703 to 774 1 to 69       69/70
(98 %)
4 diff
(94.3 %id)
AA366209 Pancreas .c 709 to 982 1 to 275       275/275
(100 %)
1 diff
(99.7 %id)
AA366448 Pancreas .c 709 to 981 1 to 273       273/273
(100 %)
0 diff
(100 %id)
AA361023   .c 718 to 984 1 to 268       268/268
(100 %)
2 diff
(99.3 %id)
AA449402   .c 719 to 1072 1 to 354   fully sequenced,   354/354
(100 %)
0 diff
(100 %id)
T96889 liver and spleen .c 720 to 1041 12 to 336   fully sequenced,   325/336
(96 %)
10 diff
(97.1 %id)
T97468 liver and spleen .c 720 to 1006 1 to 287   fully sequenced,   287/287
(100 %)
3 diff
(99.0 %id)
BF109307 pooled .c 733 to 1378 652 to 7       646/655
(98 %)
3 diff
(99.6 %id)
AI671224 pooled germ cell tumors .c 736 to 1382 647 to 1       647/647
(100 %)
2 diff
(99.7 %id)
AA781193   .c 742 to 904 163 to 1       163/163
(100 %)
2 diff
(98.8 %id)
CB853877 lung, Primary Lung Epithelial Cells .c 749 to 1382 652 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 634/634
(100 %)
0 diff
(100 %id)
AA040644 uterus .c 779 to 1033 1 to 256   fully sequenced,   256/256
(100 %)
4 diff
(98.5 %id)
AA040430 uterus .c 784 to 960 1 to 177       177/177
(100 %)
1 diff
(99.5 %id)
BF940028 brain, glioblastoma (pooled) .c 794 to 1383 590 to 1       590/590
(100 %)
2 diff
(99.7 %id)
BX358909 Placenta Cot 25-normalized .c 801 to 1350 550 to 1   fully sequenced,   550/550
(100 %)
6 diff
(99.0 %id)
AA101990 uterus .c 807 to 989 1 to 182       182/183
(99 %)
3 diff
(98.4 %id)
H93009 liver and spleen .c 825 to 1382 558 to 1       558/572
(97 %)
7 diff
(98.8 %id)
TI_154034448   .c 825 to 1382 638 to 87   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 552/934
(59 %)
42 diff
(95.6 %id)
AW055187 brain, glioblastoma (pooled) .c 828 to 1386 559 to 1       559/559
(100 %)
1 diff
(99.9 %id)
AA058688 cornea .c 838 to 1383 546 to 2       545/552
(98 %)
2 diff
(99.7 %id)
AW057512 pooled .c 840 to 1382 543 to 1       543/543
(100 %)
1 diff
(99.9 %id)
DB330950 skeletal muscle .c 848 to 1382 536 to 1       536/536
(100 %)
1 diff
(99.9 %id)
AI800594 pooled .c 853 to 1382 541 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 530/530
(100 %)
0 diff
(100 %id)
AW195361 Kidney .c 853 to 1383 532 to 2       531/532
(99 %)
3 diff
(99.5 %id)
FN146022 breast carcinoma .c 861 to 956 97 to 1     Submitted on the opposite strand 97/100
(97 %)
3 diff
(97.0 %id)
AW271301 Kidney .c 878 to 1382 505 to 1       505/505
(100 %)
2 diff
(99.7 %id)
AW292805   .c 886 to 1382 513 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 496/497
(99 %)
3 diff
(99.4 %id)
BE046993 pooled germ cell tumors .c 901 to 1383 483 to 1       483/483
(100 %)
2 diff
(99.6 %id)
FN160873 breast carcinoma .c 909 to 1011 99 to 1     Submitted on the opposite strand 99/103
(96 %)
4 diff
(96.2 %id)
AA716336 pineal gland .c 911 to 1385 479 to 4       476/479
(99 %)
2 diff
(99.6 %id)
AI128201 uterus .c 912 to 1382 471 to 1       471/471
(100 %)
7 diff
(98.6 %id)
AI628787 Kidney .c 913 to 1383 473 to 3       471/473
(99 %)
1 diff
(99.8 %id)
AI769897 2 pooled tumors (clear cell type), Kidney .c 913 to 1383 473 to 3       471/473
(99 %)
1 diff
(99.8 %id)
AI091306 pooled .c 914 to 1377 464 to 1       464/464
(100 %)
0 diff
(100 %id)
AI200257 placenta .c 914 to 1383 470 to 1       470/470
(100 %)
1 diff
(99.8 %id)
AI302809 2 pooled tumors (clear cell type), Kidney .c 914 to 1376 488 to 26   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 463/463
(100 %)
4 diff
(99.2 %id)
AI735273 aorta .c 914 to 1386 474 to 1       474/474
(100 %)
4 diff
(99.2 %id)
AI458862 pooled .c 920 to 1385 469 to 4       466/469
(99 %)
0 diff
(100 %id)
AI707638 aorta .c 920 to 1376 463 to 7       457/463
(98 %)
0 diff
(100 %id)
AW272744 colon, moderately-differentiated adenocarcinoma .c 926 to 1387 462 to 1       462/462
(100 %)
1 diff
(99.8 %id)
TI_1948217106   .c 928 to 1243 436 to 122       315/337
(93 %)
2 diff
(99.5 %id)
FN106635 breast carcinoma .c 935 to 994 62 to 1     Submitted on the opposite strand 62/63
(98 %)
2 diff
(96.9 %id)
AI824017 2 pooled tumors (clear cell type), Kidney .c 939 to 1382 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
TI_1948217747   .c 939 to 1243 428 to 124       305/327
(93 %)
2 diff
(99.4 %id)
AI307309 2 pooled tumors (clear cell type), Kidney .c 940 to 1383 446 to 3       444/446
(99 %)
0 diff
(100 %id)
AW052091 pooled .c 946 to 1385 443 to 4       440/443
(99 %)
0 diff
(100 %id)
AI880867 aorta .c 947 to 1383 441 to 5       437/441
(99 %)
0 diff
(100 %id)
FN078106 breast carcinoma .c 949 to 1054 1 to 106       106/106
(100 %)
0 diff
(100 %id)
AW473067 lymph node, lymphoma, follicular mixed small and largecell .c 953 to 1383 431 to 1       431/431
(100 %)
1 diff
(99.8 %id)
AI699923 pooled germ cell tumors .c 955 to 1382 428 to 1       428/428
(100 %)
2 diff
(99.6 %id)
FN047125 breast carcinoma .c 960 to 1057 1 to 99       99/99
(100 %)
1 diff
(99.0 %id)
BF941490 brain, glioblastoma (pooled) .c 965 to 1382 420 to 3       418/420
(99 %)
8 diff
(98.1 %id)
AI597746 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 966 to 1386 421 to 1       421/421
(100 %)
0 diff
(100 %id)
AI239461 pooled .c 967 to 1383 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AI278932 adenocarcinoma, colon .c 967 to 1382 414 to 1       414/414
(100 %)
3 diff
(99.3 %id)
AA035209 uterus .c 970 to 1376 411 to 1       411/411
(100 %)
5 diff
(98.8 %id)
AA582895 colon, colon tumor RER+ .c 974 to 1382 409 to 1       409/409
(100 %)
1 diff
(99.8 %id)
T97469 liver and spleen .c 976 to 1363 398 to 3   fully sequenced,   396/398
(99 %)
6 diff
(98.5 %id)
AI933321 anaplastic oligodendroglioma, brain .c 977 to 1352 376 to 1       376/376
(100 %)
0 diff
(100 %id)
AI758904 Kidney .c 981 to 1376 396 to 1       396/396
(100 %)
0 diff
(100 %id)
AI691016 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 982 to 1383 403 to 2       402/403
(99 %)
0 diff
(100 %id)
BE464130 pooled germ cell tumors .c 982 to 1383 403 to 2       402/403
(99 %)
1 diff
(99.8 %id)
BF222944 pooled germ cell tumors .c 982 to 1382 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
AI418284 brain, glioblastoma (pooled) .c 988 to 1376 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
N47960 multiple sclerosis lesions .c 994 to 1342 1 to 348     Submitted on the opposite strand 348/348
(100 %)
2 diff
(99.5 %id)
AA709030 uterus .c 994 to 1382 389 to 1       389/389
(100 %)
1 diff
(99.8 %id)
AI361585 brain, glioblastoma (pooled) .c 1000 to 1382 383 to 1       383/383
(100 %)
0 diff
(100 %id)
AA045521 uterus .c 1003 to 1382 383 to 1   fully sequenced,   383/383
(100 %)
3 diff
(99.3 %id)
AA502417 ovary .c 1007 to 1265 1 to 259       259/259
(100 %)
5 diff
(98.1 %id)
AA502505 ovary .c 1007 to 1328 1 to 322       322/322
(100 %)
5 diff
(98.5 %id)
AA502528 ovary .c 1007 to 1366 1 to 360       360/361
(99 %)
5 diff
(98.7 %id)
T96890 liver and spleen .c 1010 to 1363 364 to 3   fully sequenced,   362/364
(99 %)
11 diff
(97.0 %id)
AA160279   .c 1011 to 1383 373 to 1   fully sequenced,   373/373
(100 %)
1 diff
(99.8 %id)
AA449267   .c 1011 to 1383 372 to 1   fully sequenced,   372/372
(100 %)
1 diff
(99.8 %id)
AW474837 lymph node, lymphoma, follicular mixed small and largecell .c 1011 to 1376 367 to 1       367/367
(100 %)
2 diff
(99.5 %id)
F20467 pectoral muscle (after mastectomy) .c 1015 to 1377 1 to 364       364/364
(100 %)
7 diff
(98.1 %id)
AI149430 placenta .c 1019 to 1381 363 to 1       363/363
(100 %)
4 diff
(98.9 %id)
AI261533 adenocarcinoma, colon .c 1021 to 1382 362 to 1       362/362
(100 %)
0 diff
(100 %id)
AI300367 carcinoid, lung .c 1022 to 1381 360 to 1       360/360
(100 %)
1 diff
(99.8 %id)
AA411404 ovarian tumor, ovary .c 1032 to 1376 345 to 1       345/345
(100 %)
0 diff
(100 %id)
AA576365 colon, colon tumor RER+ .c 1032 to 1376 345 to 1       345/345
(100 %)
1 diff
(99.8 %id)
AI199994 placenta .c 1032 to 1383 352 to 1       352/352
(100 %)
0 diff
(100 %id)
BG187651   .c 1037 to 1382 1 to 346   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 346/347
(99 %)
6 diff
(98.3 %id)
BG201539   .c 1038 to 1382 1 to 345   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 345/345
(100 %)
4 diff
(98.9 %id)
AA099553 uterus .c 1041 to 1383 348 to 1       348/434
(80 %)
6 diff
(98.7 %id)
BG218456   .c 1042 to 1376 5 to 338       334/346
(96 %)
13 diff
(96.3 %id)
AA040431 uterus .c 1042 to 1382 340 to 1       340/356
(95 %)
2 diff
(99.5 %id)
AA810540 germinal center B cell .c 1042 to 1382 355 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 340/340
(100 %)
0 diff
(100 %id)
AA974453 2 pooled tumors (clear cell type), Kidney .c 1042 to 1383 344 to 3       342/351
(97 %)
1 diff
(99.8 %id)
AI373386 uterus .c 1047 to 1382 336 to 1       336/336
(100 %)
0 diff
(100 %id)
AI474422 Prostate .c 1051 to 1383 335 to 3       333/335
(99 %)
0 diff
(100 %id)
AI824266 2 pooled tumors (clear cell type), Kidney .c 1054 to 1383 334 to 5       330/334
(98 %)
1 diff
(99.8 %id)
CA443549 lung, Metastatic Chondrosarcoma .c 1056 to 1382 345 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 327/327
(100 %)
4 diff
(98.8 %id)
CD299040 Blood vessels - aorta, basilar and artery .c 1060 to 1388 1 to 329       329/921
(35 %)
7 diff
(99.3 %id)
TI_1948216772   .c 1067 to 1243 299 to 123       177/199
(88 %)
0 diff
(100 %id)
FN075610 breast carcinoma .c 1068 to 1162 95 to 1     Submitted on the opposite strand 95/95
(100 %)
0 diff
(100 %id)
AA731356 germinal center B cell .c 1079 to 1386 330 to 23   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 308/308
(100 %)
0 diff
(100 %id)
AI161128 uterus .c 1084 to 1388 306 to 2       305/306
(99 %)
2 diff
(99.4 %id)
FN063981 breast carcinoma .c 1095 to 1192 100 to 1     Submitted on the opposite strand 100/101
(99 %)
1 diff
(99.1 %id)
FN124479 breast carcinoma .c 1099 to 1179 81 to 3     Submitted on the opposite strand 79/81
(97 %)
2 diff
(97.6 %id)
FN079817 breast carcinoma .c 1101 to 1192 92 to 1     Submitted on the opposite strand 92/92
(100 %)
0 diff
(100 %id)
BE465129 carcinoid, lung .c 1103 to 1382 280 to 1       280/280
(100 %)
1 diff
(99.7 %id)
AI305839 2 pooled tumors (clear cell type), Kidney .c 1111 to 1382 283 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 272/272
(100 %)
1 diff
(99.7 %id)
CB045883 2 pooled tumors (clear cell type), Kidney .c 1171 to 1382 239 to 27   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 213/213
(100 %)
3 diff
(98.6 %id)
CD684503 normal nasopharynx .d 1 to 682 22 to 703   tiling clone,   682/703
(97 %)
6 diff
(99.2 %id)
AF354930 Liver .d 376 to 1356 1 to 981 exact     981/981
(100 %)
5 diff
(99.5 %id)
NM_022349.2   .d 376 to 1792 1 to 1417 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1417/1417
(100 %)
4 diff
(99.8 %id)
AU310249 neuroblastoma .d 466 to 1053 13 to 600     Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 588/600
(98 %)
6 diff
(99.0 %id)
DA962239 stomach .d 467 to 1297 2 to 828 F93L F95L I96S I97S S98L ... capped   829/831
(99 %)
12 diff
(98.6 %id)
BI771044 pooled lung and spleen .d 468 to 1344 1 to 876 L206P R207A W208V K209E Q210T ...     876/876
(100 %)
9 diff
(99.0 %id)
TI_57179706   .d 469 to 1344 35 to 909 L206P R207A W208V K209E Q210T ...     875/909
(96 %)
18 diff
(98.1 %id)
BC108728 Peripheral Nervous System, sympathetictrunk .d 473 to 2277 1 to 1805 A104S tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1805/1805
(100 %)
6 diff
(99.7 %id)
CR625448 Placenta Cot 25-normalized .d 473 to 1763 1 to 1291 exact tiling clone,   1291/1291
(100 %)
0 diff
(100 %id)
AL551751 placenta, Placenta Cot 25-normalized .d 473 to 983 1 to 511   fully sequenced,   511/511
(100 %)
0 diff
(100 %id)
AF142409   .d 518 to 1792 1 to 1274 T185S AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1274/1274
(100 %)
7 diff
(99.5 %id)
CR609705 Placenta Cot 25-normalized .d 524 to 1762 1 to 1239 exact     1239/1239
(100 %)
0 diff
(100 %id)
BX340264 Placenta Cot 25-normalized .d 524 to 983 1 to 460   fully sequenced,   460/460
(100 %)
1 diff
(99.8 %id)
AF350503   .d 529 to 1783 1 to 1255 K107R T110S     1255/1258
(99 %)
10 diff
(99.3 %id)
H59637 liver and spleen .d 570 to 979 1 to 414       414/417
(99 %)
9 diff
(97.9 %id)
DN998946 bone marrow .d 570 to 1335 1 to 766 V119F G217W     766/766
(100 %)
9 diff
(98.9 %id)
W01926 liver and spleen .d 785 to 1005 1 to 222       222/225
(98 %)
6 diff
(97.4 %id)
BU929094 placenta .d 865 to 1406 1 to 548   AAA   548/554
(98 %)
20 diff
(96.4 %id)
TI_154115116   .d 892 to 1792 977 to 85   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 893/986
(90 %)
26 diff
(97.4 %id)
BX340263 Placenta Cot 25-normalized .d 922 to 1762 841 to 1   fully sequenced,   841/841
(100 %)
28 diff
(96.7 %id)
AL575243 placenta, Placenta Cot 25-normalized .d 926 to 1754 834 to 10   fully sequenced,   825/834
(98 %)
13 diff
(98.5 %id)
DB103858 thymus .d 941 to 1496 2 to 557   capped   556/556
(100 %)
4 diff
(99.3 %id)
AA344621 gall bladder .d 1024 to 1294 1 to 273       273/273
(100 %)
3 diff
(99.0 %id)
AW952968   .d 1025 to 1548 1 to 526       526/528
(99 %)
19 diff
(96.5 %id)
TI_149289580   .d 1038 to 1794 832 to 83       750/1005
(74 %)
17 diff
(98.4 %id)
BI468337 insulinoma, Pancreas .d 1063 to 1597 8 to 541       534/541
(98 %)
10 diff
(98.2 %id)
CK903209 insulinoma, Pancreas .d 1063 to 1623 8 to 568       561/568
(98 %)
10 diff
(98.3 %id)
BP420140 small intestine .d 1081 to 1581 1 to 501     Submitted on the opposite strand 501/501
(100 %)
7 diff
(98.7 %id)
CD370897 Alveolar Macrophage, lung .d 1129 to 1792 682 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 664/664
(100 %)
7 diff
(99.0 %id)
CA448987 Chondrosarcoma, Left Pelvis .d 1146 to 1792 665 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 647/647
(100 %)
4 diff
(99.4 %id)
BG196874   .d 1161 to 1645 1 to 486       486/791
(61 %)
24 diff
(97.0 %id)
BU077433 insulinoma, Pancreas .d 1192 to 1792 618 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 601/601
(100 %)
4 diff
(99.4 %id)
CK820365 insulinoma, Pancreas .d 1193 to 1792 618 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 600/600
(100 %)
4 diff
(99.4 %id)
BU681720 lung .d 1194 to 1794 621 to 21       601/621
(96 %)
0 diff
(100 %id)
BM511563 insulinoma, Pancreas .d 1225 to 1792 585 to 18   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 568/568
(100 %)
4 diff
(99.3 %id)
AA633231 colon, colon tumor RER+ .d 1244 to 1787 544 to 1       544/544
(100 %)
5 diff
(99.1 %id)
FN105547 breast carcinoma .d 1273 to 1373 102 to 1     Submitted on the opposite strand 102/102
(100 %)
5 diff
(95.1 %id)
AI984164 adenocarcinoma, Pancreas .d 1292 to 1554 262 to 1       262/262
(100 %)
8 diff
(97.0 %id)
AW025125 Kidney .d 1292 to 1792 515 to 15   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 501/501
(100 %)
4 diff
(99.3 %id)
BQ029245 lung, Metastatic Chondrosarcoma .d 1299 to 1792 512 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 494/494
(100 %)
4 diff
(99.2 %id)
BE046422 colon, juvenile granulosa tumor .d 1314 to 1542 229 to 1       229/229
(100 %)
4 diff
(98.3 %id)
N54311 liver and spleen .d 1325 to 1792 475 to 1       475/475
(100 %)
14 diff
(97.1 %id)
AI372838 uterus .d 1331 to 1792 475 to 14   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 462/462
(100 %)
4 diff
(99.2 %id)
AW264279 brain, three pooled meningiomas .d 1336 to 1542 207 to 1       207/207
(100 %)
6 diff
(97.2 %id)
BI468336 insulinoma, Pancreas .d 1348 to 1792 457 to 12   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 446/446
(100 %)
11 diff
(97.6 %id)
AW613141 colon, moderately-differentiated adenocarcinoma .d 1359 to 1542 184 to 1       184/184
(100 %)
3 diff
(98.4 %id)
H59599 liver and spleen .d 1371 to 1772 401 to 1       401/401
(100 %)
5 diff
(98.8 %id)
AA610850 lung, lung tumor .d 1376 to 1792 417 to 1       417/417
(100 %)
0 diff
(100 %id)
AI833034 colon .d 1384 to 1788 405 to 1       405/405
(100 %)
3 diff
(99.3 %id)
AV758743 bone marrow .d 1385 to 1791 96 to 494   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 463/494
(93 %)
24 diff
(95.2 %id)
CD370441 Alveolar Macrophage, lung .d 1408 to 1792 405 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 387/391
(98 %)
2 diff
(99.5 %id)
N71028 liver and spleen .d 1413 to 1792 386 to 1       386/387
(99 %)
11 diff
(97.2 %id)
AI421352 brain, glioblastoma (pooled) .d 1431 to 1788 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
TI_149278210   .d 1445 to 2135 769 to 79   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 691/692
(99 %)
5 diff
(99.3 %id)
BU678303 lung .d 1541 to 2135 610 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 595/595
(100 %)
1 diff
(99.9 %id)
AI949985 2 pooled tumors (clear cell type), Kidney .d 1545 to 1792 266 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 248/248
(100 %)
1 diff
(99.6 %id)
FN145544 breast carcinoma .d 1560 to 1631 1 to 71       71/72
(98 %)
2 diff
(97.3 %id)
DB342690 thymus .d 1579 to 1792 217 to 1       217/217
(100 %)
3 diff
(98.7 %id)
AI273141 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .d 1602 to 1792 209 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 191/191
(100 %)
0 diff
(100 %id)
TI_154094481   .d 1638 to 2277 764 to 120   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 645/678
(95 %)
17 diff
(97.5 %id)
AW182457 pooled .d 1699 to 2276 578 to 1       578/578
(100 %)
1 diff
(99.9 %id)
BM992240 Bone, Subchondral Bone .d 1703 to 2277 593 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 575/575
(100 %)
1 diff
(99.9 %id)
AU309772 neuroblastoma .d 1712 to 2279 600 to 32       569/600
(94 %)
0 diff
(100 %id)
AU310250 neuroblastoma .d 1753 to 2277 560 to 36   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 525/525
(100 %)
2 diff
(99.7 %id)
AA152220 uterus .d 1815 to 2136 1 to 325       325/325
(100 %)
6 diff
(98.2 %id)
AA031704.
matches multiple genes
uterus .d 1817 to 2269 1 to 458     also hits gene GNAQ 458/458
(100 %)
6 diff
(98.7 %id)
AI922795 adenocarcinoma, Pancreas .d 1836 to 2278 445 to 3       443/445
(99 %)
0 diff
(100 %id)
CA436521 Bone, Subchondral Bone .d 1839 to 2277 457 to 19   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 439/439
(100 %)
0 diff
(100 %id)
AA974771 pooled germ cell tumors .d 1843 to 2283 448 to 8       441/448
(98 %)
0 diff
(100 %id)
FN063768 breast carcinoma .d 1851 to 1951 1 to 101       101/101
(100 %)
0 diff
(100 %id)
AA976534 pooled germ cell tumors .d 1868 to 2283 423 to 8       416/423
(98 %)
0 diff
(100 %id)
AA045294 uterus .d 2009 to 2276 1 to 269   fully sequenced,   269/269
(100 %)
0 diff
(100 %id)
AW148422 Kidney, renal cell tumor .d 2044 to 2277 258 to 25   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 234/234
(100 %)
0 diff
(100 %id)
N49171 multiple sclerosis lesions .d 2045 to 2239 197 to 1     Submitted on the opposite strand 197/197
(100 %)
3 diff
(98.5 %id)
FN055622 breast carcinoma .d 2056 to 2163 1 to 108       108/108
(100 %)
2 diff
(98.2 %id)
AA713812 germinal center B cell .d 2080 to 2277 213 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 198/198
(100 %)
0 diff
(100 %id)
GD145795   .d 2099 to 2277 1 to 180   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 180/180
(100 %)
5 diff
(97.3 %id)
AA736644 germinal center B cell .d 2111 to 2281 193 to 23   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 171/171
(100 %)
0 diff
(100 %id)
FN053067 breast carcinoma .d 2126 to 2250 1 to 125       125/125
(100 %)
2 diff
(98.4 %id)
AW470859 2 pooled tumors (clear cell type), Kidney .d 2126 to 2283 158 to 1       158/158
(100 %)
7 diff
(95.6 %id)
BF593722 brain, glioblastoma (pooled) .d 2169 to 2684 516 to 1       516/516
(100 %)
1 diff
(99.9 %id)
DB334311 stomach .d 2186 to 2684 498 to 1   tiling clone,   498/498
(100 %)
4 diff
(99.2 %id)
FN126494 breast carcinoma .d 2189 to 2275 85 to 2     Submitted on the opposite strand 84/85
(98 %)
0 diff
(100 %id)
FN140128 breast carcinoma .d 2189 to 2276 87 to 4     Submitted on the opposite strand 84/87
(96 %)
0 diff
(100 %id)
BP389999 pancreatic islet .d 2189 to 2687 1 to 499     Submitted on the opposite strand 499/500
(99 %)
2 diff
(99.6 %id)
AA031623.
matches multiple genes
uterus .d 2233 to 2685 456 to 5     also hits gene RSF1andRPS20P27 452/456
(99 %)
0 diff
(100 %id)
AA045175 uterus .d 2246 to 2696 459 to 1   tiling clone, fully sequenced,   459/459
(100 %)
7 diff
(98.5 %id)
AA992750   .d 2249 to 2685 439 to 4       436/439
(99 %)
0 diff
(100 %id)
AI863568 2 pooled tumors (clear cell type), Kidney .d 2271 to 2685 417 to 3       415/417
(99 %)
0 diff
(100 %id)
AA150151 uterus .d 2284 to 2685 410 to 5       406/445
(91 %)
0 diff
(100 %id)
AI634797 Kidney .d 2306 to 2684 388 to 10   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 379/379
(100 %)
2 diff
(99.5 %id)
R58859   .d 2387 to 2684 298 to 1       298/298
(100 %)
0 diff
(100 %id)
AI668883 Prostate .d 2435 to 2687 253 to 1       253/253
(100 %)
0 diff
(100 %id)
AK301387 synovial membrane tissue from rheumatoidarthritis .e 1 to 1536 1 to 1536 V13A tiling clone,   1536/1536
(100 %)
6 diff
(99.7 %id)
DA980360 synovial membrane tissue from rheumatioidarthritis .e 2 to 559 2 to 559   capped   558/558
(100 %)
1 diff
(99.9 %id)
DC295707 synovial membrane tissue from rheumatioidarthritis .f 1 to 508 3 to 510   tiling clone,   510/510
(100 %)
1 diff
(99.9 %id)
CD688880 normal nasopharynx .f 165 to 761 22 to 617   tiling clone,   596/617
(96 %)
8 diff
(98.8 %id)
NM_152851.1   .f 477 to 1907 1 to 1431 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 1431/1431
(100 %)
1 diff
(100.0 %id)
BG506772 lung .f 594 to 1362 1 to 768 Q34R D35I S36A L37*     770/768
(100 %)
16 diff
(98.0 %id)
AB013104   .f 639 to 1500 1 to 862 exact tiling clone,   862/862
(100 %)
3 diff
(99.7 %id)
AA460478   .f 639 to 1059 1 to 421   fully sequenced,   421/421
(100 %)
2 diff
(99.6 %id)
AI741604 pooled .f 861 to 1503 643 to 1       643/648
(99 %)
10 diff
(98.5 %id)
AI740946 pooled .f 970 to 1503 534 to 1   tiling clone,   534/537
(99 %)
2 diff
(99.7 %id)
AA461046   .f 1057 to 1501 447 to 3   fully sequenced,   445/447
(99 %)
0 diff
(100 %id)
AA448335   .f 1076 to 1501 429 to 4       426/429
(99 %)
2 diff
(99.6 %id)
AI278475 placenta .f 1086 to 1501 419 to 4       416/419
(99 %)
0 diff
(100 %id)
CB999573 Pooled-Skin .g 1 to 648 1 to 657 T121S L130P E132G F133I C134L ... tiling clone, AAA   657/780
(84 %)
34 diff
(95.7 %id)
BG570509 lung .h 1 to 780 1 to 784 Q56R D57I S58A L59* tiling clone,   784/784
(100 %)
19 diff
(97.6 %id)
BX484249   .i 1 to 549 1 to 549 exact tiling clone,   549/549
(100 %)
4 diff
(99.3 %id)
CF994300 Human Placenta, placenta .j 1 to 696 29 to 734 V2A S50L Q51P A52G E53R ... tiling clone,   706/735
(96 %)
26 diff
(96.5 %id)
AV727725 hypothalamus .k 1 to 559 1 to 558 F93X G114E tiling clone,   558/648
(86 %)
13 diff
(98.0 %id)
AI733416 Kidney, kidney tumor .k 240 to 834 595 to 1   tiling clone,   595/595
(100 %)
0 diff
(100 %id)
AA976371 Kidney, kidney tumor .k 442 to 833 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
BE168196 head_neck .k 643 to 1121 505 to 27   tiling clone, Submitted on the opposite strand 479/505
(94 %)
0 diff
(100 %id)
BE927783 colon .k 809 to 1090 15 to 296       282/299
(94 %)
6 diff
(98.0 %id)
BE927804 colon .k 809 to 1082 16 to 288       273/289
(94 %)
4 diff
(98.7 %id)
CB959119 Pooled-Glandular .k 1014 to 1749 1 to 744   tiling clone,   744/749
(99 %)
13 diff
(98.3 %id)
BF095733 uterus_tumor .k 1018 to 1332 328 to 14       315/347
(90 %)
0 diff
(100 %id)
BF095444 uterus_tumor .k 1023 to 1392 371 to 2       370/371
(99 %)
0 diff
(100 %id)
BF380939 uterus_tumor .k 1068 to 1375 1 to 308       308/308
(100 %)
7 diff
(97.8 %id)
AV706345 adrenal gland .l 1 to 586 116 to 701 I27M F29L tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 586/701
(83 %)
7 diff
(99.1 %id)
AA465003 ovarian tumor, ovary .m 1 to 248 1 to 248   tiling clone,   248/248
(100 %)
3 diff
(98.8 %id)
DC297033   .m 29 to 605 1 to 577 S98F P101S tiling clone,   577/577
(100 %)
3 diff
(99.5 %id)
DC341189 thalamus .n 1 to 573 1 to 573   tiling clone,   573/573
(100 %)
4 diff
(99.4 %id)
AK026454 ileal mucosa .n 562 to 2967 10 to 2416 exact tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2407/2407
(100 %)
5 diff
(99.8 %id)
DA948089 Spleen .n 581 to 1103 2 to 524 exact capped   523/523
(100 %)
2 diff
(99.7 %id)
DA934926 Spleen .n 624 to 1203 2 to 579 exact capped   578/578
(100 %)
2 diff
(99.7 %id)
DA641676 Liver .n 625 to 1350 2 to 733 exact capped   732/732
(100 %)
7 diff
(99.1 %id)
BX644139   .n 629 to 1114 1 to 486 exact     486/486
(100 %)
2 diff
(99.6 %id)
DA594774 lung .n 633 to 1213 2 to 582 L14M P15T capped   581/581
(100 %)
3 diff
(99.5 %id)
DA815659   .n 675 to 1248 2 to 575 E44G capped   574/574
(100 %)
1 diff
(99.9 %id)
DA974053 synovial membrane tissue from rheumatioidarthritis .n 677 to 1236 2 to 562 exact capped   561/561
(100 %)
3 diff
(99.5 %id)
DA934684 Spleen .n 2128 to 2707 2 to 581   tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
AF172819 aorta .o 1 to 1124 1 to 1124 exact tiling clone, AAA   1124/1124
(100 %)
2 diff
(99.9 %id)
AI148352 heart .o 663 to 1125 463 to 1       463/463
(100 %)
1 diff
(99.8 %id)
AW452710   .o 669 to 1136 473 to 6       468/473
(98 %)
0 diff
(100 %id)
BF338860 brain, glioblastoma with EGFR amplification .o 803 to 1521 1 to 721       721/900
(80 %)
33 diff
(96.4 %id)
BP378998 uterus .o 961 to 1302 243 to 584       342/584
(58 %)
6 diff
(99.0 %id)
DA361433 subthalamic nucleus .o 995 to 1547 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
BU787864 insulinoma, Pancreas .o 1116 to 1693 29 to 606   tiling clone, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 578/606
(95 %)
6 diff
(99.1 %id)
BF369181 placenta_normal .o 1146 to 1529 23 to 405       383/405
(94 %)
6 diff
(98.6 %id)
AA088605 uterus .o 1662 to 2081 1 to 421   tiling clone,   421/421
(100 %)
2 diff
(99.6 %id)
BU787589 insulinoma, Pancreas .o 2273 to 2911 655 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 639/639
(100 %)
3 diff
(99.6 %id)
AA088175 uterus .o 2429 to 2917 495 to 1   tiling clone,   495/495
(100 %)
8 diff
(98.4 %id)
DA470642   .p 1 to 548 2 to 549   tiling clone, capped   548/548
(100 %)
1 diff
(99.9 %id)
DB220756 trachea .p 285 to 855 2 to 573   tiling clone, capped   572/572
(100 %)
3 diff
(99.5 %id)
DA936899 Spleen .p 795 to 1365 2 to 572 exact tiling clone, capped   571/571
(100 %)
1 diff
(99.9 %id)
DA676574   .q 1 to 551 2 to 552 exact tiling clone, capped   551/551
(100 %)
1 diff
(99.9 %id)
BE156785 head_neck Gene MS4A6A, variant not shown         Submitted on the opposite strand    
DA380125 thalamus Gene MS4A6A, variant not shown       capped      
CD706348 normal nasopharynx Gene MS4A6A, variant not shown         This clone was ignored    
CD706630 normal nasopharynx Gene MS4A6A, variant not shown         Suspected internal deletion, this clone was ignored    
AV733584 pheochromocytoma Gene MS4A6A, variant not shown         This clone was ignored    
AV734415 pheochromocytoma Gene MS4A6A, variant not shown         Suspected internal deletion, this clone was ignored    
AV733821 pheochromocytoma Gene MS4A6A, variant not shown         This clone was ignored    
AV733784 pheochromocytoma Gene MS4A6A, variant not shown         This clone was ignored    
AV734019 pheochromocytoma Gene MS4A6A, variant not shown         Suspected internal deletion, this clone was ignored    
AV711858   Gene MS4A6A, variant not shown         Suspected internal deletion, this clone was ignored    
AV716911   Gene MS4A6A, variant not shown         Suspected internal deletion, this clone was ignored    
AV714513   Gene MS4A6A, variant not shown         This clone was ignored    
AV716310   Gene MS4A6A, variant not shown         This clone was ignored    
AV717594   Gene MS4A6A, variant not shown         This clone was ignored    
AL602729 human skeletal muscle Gene MS4A6A, variant not shown              
AV698561 hepatocellular carcinoma Gene MS4A6A, variant not shown         This clone was ignored    
AV700492 hepatocellular carcinoma Gene MS4A6A, variant not shown         This clone was ignored    
AV685678 hepatocellular carcinoma Gene MS4A6A, variant not shown         This clone was ignored    
AV699902 hepatocellular carcinoma Gene MS4A6A, variant not shown         This clone was ignored    
AV692945 hepatocellular carcinoma Gene MS4A6A, variant not shown         This clone was ignored    
AV700810 hepatocellular carcinoma Gene MS4A6A, variant not shown         This clone was ignored    
AV659131 corresponding non cancerous liver tissue Gene MS4A6A, variant not shown         Submitted on the opposite strand    
AV720078 corresponding non cancerous liver tissue Gene MS4A6A, variant not shown         Submitted on the opposite strand    
N59386 liver and spleen Gene MS4A6A, variant not shown         Suspected internal deletion, this clone was ignored    
N77074 liver and spleen Gene MS4A6A, variant not shown         Suspected internal deletion, this clone was ignored    
AA441988   Gene MS4A6A, variant not shown              
AA441989   Gene MS4A6A, variant not shown              
AI375656 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene MS4A6A, variant not shown              
AW510641 pooled Gene MS4A6A, variant not shown              
BG540868 lung Gene MS4A6A, variant not shown         Suspected internal deletion, suspected internal deletion, this clone was ignored    
CB155905 Liver Gene MS4A6A, variant not shown              
BM695459 eye, optic nerve Gene MS4A6A, variant not shown       fully sequenced, Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)    
BU728879 eye, optic nerve Gene MS4A6A, variant not shown       fully sequenced, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base)    
DB259147 uterus Gene MS4A6A, variant not shown       capped      
DB351550 uterus Gene MS4A6A, variant not shown              
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C